Literature DB >> 3466181

A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.

Y Itoh, E Takai, H Ohnuma, K Kitajima, F Tsuda, A Machida, S Mishiro, T Nakamura, Y Miyakawa, M Mayumi.   

Abstract

The S gene encoding the major surface polypeptide of hepatitis B virus is preceded by the region pre-S(2) with a capacity to code for 55 amino acid residues. In the product of region pre-S(2), the sequence of 19 amino acid residues (amino acids 14-32 from the N terminus) representing an area of high local hydrophilicity is shared by viral strains of subtypes adr, ayw, and ayr; residue 22, phenylalanine, is replaced by leucine in a strain of the other subtype, adw. A synthetic peptide vaccine involving these 19 amino acid residues, when given to two chimpanzees, raised antibodies that bound to viral particles and protected the animals from challenge with 10(6) chimpanzee infectious doses of hepatitis B virus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3466181      PMCID: PMC387097          DOI: 10.1073/pnas.83.23.9174

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

Review 1.  Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association.

Authors:  W Szmuness
Journal:  Prog Med Virol       Date:  1978

2.  Hepatitis B e antigen and infectivity of hepatitis B virus.

Authors:  T Shikata; T Karasawa; K Abe; T Uzawa; H Suzuki; T Oda; M Imai; M Mayumi; Y Moritsugu
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

3.  Large-scale isolation of Dane particles from plasma containing hepatitis B antigen and deomnstration of circular double-stranded DNA molecule extruding directly from their cores.

Authors:  T Takahashi; S Nakagawa; T Hashimoto; K Takahashi; M Imai
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

4.  Detection of additional antigenic determinants of hepatitis B antigen.

Authors:  W H Bancroft; F K Mundon; P K Russell
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

Review 5.  Solid-phase peptide synthesis.

Authors:  R B Merrifield
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1969

6.  Demonstration of albumin receptors on isolated human hepatocytes by light and scanning electron microscopy.

Authors:  A Trevisan; F Gudat; R Guggenheim; G Krey; U Dürmüller; G Lüond; M Düggelin; J Landmann; P Tondelli; L Bianchi
Journal:  Hepatology       Date:  1982 Nov-Dec       Impact factor: 17.425

7.  A receptor for polymerized human and chimpanzee albumins on hepatitis B virus particles co-occurring with HBeAg.

Authors:  M Imai; Y Yanase; T Nojiri; Y Miyakawa; M Mayumi
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

8.  A 49,000-dalton polypeptide bearing all antigenic determinants and full immunogenicity of 22-nm hepatitis B surface antigen particles.

Authors:  S Mishiro; M Imai; K Takahashi; A Machida; T Gotanda; Y Miyakawa; M Mayumi
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

9.  New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates.

Authors:  F T Liu; M Zinnecker; T Hamaoka; D H Katz
Journal:  Biochemistry       Date:  1979-02-20       Impact factor: 3.162

10.  Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant.

Authors:  P K Bhatnagar; E Papas; H E Blum; D R Milich; D Nitecki; M J Karels; G N Vyas
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

View more
  54 in total

1.  DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines.

Authors:  H L Davis; M J McCluskie; J L Gerin; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Male-specific W4P/R mutation in the pre-S1 region of hepatitis B virus, increasing the risk of progression of liver diseases in chronic patients.

Authors:  Seoung-Ae Lee; Ki-Jeong Kim; Dong-Won Kim; Bum-Joon Kim
Journal:  J Clin Microbiol       Date:  2013-09-11       Impact factor: 5.948

Review 3.  Recombinant avirulent salmonellae as oral vaccine carriers.

Authors:  F Schödel
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

Review 4.  Nature and display of hepatitis B virus envelope proteins and the humoral immune response.

Authors:  A Alberti; W H Gerlich; K H Heermann; P Pontisso
Journal:  Springer Semin Immunopathol       Date:  1990

Review 5.  Viral and cellular determinants involved in hepadnaviral entry.

Authors:  Dieter Glebe; Stephan Urban
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 6.  Hepatology.

Authors:  P M Harrison; J Y Lau; R Williams
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

Review 7.  Viral hepatitis.

Authors:  J Y Lau; G J Alexander; A Alberti
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 8.  Genetic variation of occult hepatitis B virus infection.

Authors:  Hui-Lan Zhu; Xu Li; Jun Li; Zhen-Hua Zhang
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

9.  Effect of carrier selection on immunogenicity of protein conjugate vaccines against Plasmodium falciparum circumsporozoites.

Authors:  J U Que; S J Cryz; R Ballou; E Fürer; M Gross; J Young; G F Wasserman; L A Loomis; J C Sadoff
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

10.  The interaction between native serum albumin and hepatitis B virus.

Authors:  X Y Lu; G B Yao; Y F Tian
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.